DENVER — In a phase 1b trial, subretinal delivery of a human stem cell-derived retinal pigment epithelium yielded visual improvements in patients with advanced geographic atrophy, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results